Push Admin

Philippines approves emergency use of J&J, Bharat Biotech COVID-19 vaccines

Article (news)

ABS-CBN News

<div class="embed-wrap"><figure data-feedback="fb:likes,fb:comments"><img src="https://sa.kapamilya.com/absnews/abscbnnews/media/2021/reuters/03/01/johnson.jpg"/><figcaption>A lab worker holds a vial of Johnson &amp; Johnson&#x27;s Janssen COVID-19 vaccine candidate in an undated photograph. <em>Johnson &amp; Johnson, Handout/Reuters</em></figcaption></figure></div><p>MANILA – The Food and Drug Administration (FDA) has allowed the emergency use of COVID-19 vaccines made by Johnson &amp; Johnson and India&#x27;s Bharat Biotech, it said on Tuesday.</p><p>Both vaccines can be administered to people aged 18 and above in the Philippines, the agency chief, Rolando Enrique Domingo, said in a mobile text message.</p><p>The benefits of Bharat and J&amp;J&#x27;s vaccines &quot;outweigh&quot; their risk, Domingo said in a public briefing. <br/> <br/>Bharat Biotech needs to submit one more document to drug regulators before it can import its COVID-19 shots, he said. </p><p>As for Johnson &amp; Johnson&#x27;s Janssen vaccine, US experts are investigating 7 reports of blood clots out of 7 million inoculated people, said Domingo. </p><p>The FDA urged the Department of Health to come up with &quot;very clear guidelines&quot; before Janssen is rolled out so that those inoculated would know what effects to watch out for and where to seek medical help, he said. </p><p>Janssen is cleared for emergency use in 40 countries, and is included in the emergency listing of the World Health Organization, he said. </p><figure class="op-interactive"><iframe allow="autoplay; fullscreen" frameBorder="0" height="100%" id="ivsplayer01" scrolling="no" src="https://player.ivideosmart.com/ivsplayer/v4/dist/html/iframe-src.html?iframeid=ivsplayer01&amp;key=e8c22c015ca9eafa76f1e3edfa03c603&amp;spid=3001339&amp;vid=1665390" width="100%"></iframe></figure><div class="iwantbar"><em>Video courtesy of PTV</em></div><p>J&amp;J is conducting late-stage clinical trials for its COVID-19 vaccine in the Philippines. </p><p>The single-shot coronavirus vaccines developed by J&amp;J&#x27;s unit Janssen and Bharat Biotech&#x27;s Covaxin are the fifth and sixth to receive emergency use approval in the Philippines, which is battling one of the worst outbreaks in Asia.</p><ul class="op-related-articles">	<li><a href="https://news.abs-cbn.com/news/04/05/21/johnson-johnsons-janssen-applies-for-emergency-use-authorization-of-its-covid-19-vaccine-in-ph">Johnson &amp; Johnson’s Janssen applies for emergency use authorization of its COVID-19 vaccine in PH</a></li>	<li><a href="https://news.abs-cbn.com/news/03/09/21/covaxin-maker-can-allocate-at-least-10m-covid-19-vaccine-doses-for-ph-distributor">Covaxin maker can allocate at least 10M COVID-19 vaccine doses for PH - distributor</a></li></ul><p>The Philippines earlier cleared the COVID-19 shots of Pfizer, AstraZeneca, Gamaleya Institute, and Sinovac Biotech. </p><p>Worldwide, Hungary granted the most number of emergency use authorizations at 8, said Domingo. </p><p>There is no longer any pending application for EUA with the Philippine FDA, he said. </p><p>Chinese firm Sinopharm Biotech has yet to submit requirements for its EUA application, Domingo said. <br/> <br/><strong>– With reports from Jamaine Punzalan, ABS-CBN News; Reuters</strong></p><figure class="op-interactive"><iframe allow="autoplay; fullscreen" frameBorder="0" height="100%" id="ivsplayer01" scrolling="no" src="https://player.ivideosmart.com/ivsplayer/v4/dist/html/iframe-src.html?iframeid=ivsplayer01&amp;key=e8c22c015ca9eafa76f1e3edfa03c603&amp;spid=3001339&amp;vid=1665285" width="100%"></iframe></figure><div class="iwantbar">Watch more in <a href="//www.iwantv.com.ph/">iWantv</a> or <a href="//tfc.tv/">TFC.tv</a></div>

<p>The Food and Drug Administration (FDA) has allowed the emergency use of COVID-19 vaccines made by Johnson & Johnson and India's Bharat Biotech, it said on Tuesday.</p>

The Food and Drug Administration (FDA) has allowed the emergency use of COVID-19 vaccines made by Johnson & Johnson and India's Bharat Biotech, it said on Tuesday.